By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Pharmaceuticals
- Report Detail
Global Anti-Malarial Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Anti-Malarial Drug manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Anti-Malarial Drug market. Further, it explains the major drivers and regional dynamics of the global Anti-Malarial Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- GlaxoSmithKline
- Ranbaxy
- Zydus Cadila
- Alvizia
- Bayer
- Ipca
- Merck
- F. Hoffmann-La Roche
- Novartis
- Pfizer
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Anti-Malarial Drug Segment by Type
- Plasmodium Falciparum
- Plasmodium Vivax
- Plasmodium Malariae
- Plasmodium Ovale
Anti-Malarial Drug Segment by Application
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Anti-Malarial Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Anti-Malarial Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Anti-Malarial Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-Malarial Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Malarial Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Anti-Malarial Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Anti-Malarial Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, Bayer, Ipca, Merck, F. Hoffmann-La Roche and Novartis, etc.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Anti-Malarial Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Vivax
1.2.4 Plasmodium Malariae
1.2.5 Plasmodium Ovale
1.3 Market Segment by Application
1.3.1 Global Anti-Malarial Drug Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Anti-Malarial Drug Market Size (2017-2028)
2.1.1 Global Anti-Malarial Drug Revenue (2017-2028)
2.1.2 Global Anti-Malarial Drug Sales (2017-2028)
2.2 Global Anti-Malarial Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Anti-Malarial Drug Sales by Regions (2017-2022)
2.2.2 Global Anti-Malarial Drug Revenue by Regions (2017-2022)
2.3 Global Anti-Malarial Drug Market Size Forecast by Region
2.3.1 Global Anti-Malarial Drug Sales Forecast by Region (2023-2028)
2.3.2 Global Anti-Malarial Drug Revenue Forecast by Region (2023-2028)
2.4 Global Top Anti-Malarial Drug Regions (Countries) Ranking by Market Size
2.5 Anti-Malarial Drug Market Dynamics
2.5.1 Anti-Malarial Drug Market Trends
2.5.2 Anti-Malarial Drug Market Drivers
2.5.3 Anti-Malarial Drug Market Challenges
2.5.4 Anti-Malarial Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-Malarial Drug Manufacturers by Sales (2017-2022)
3.1.1 Global Anti-Malarial Drug Sales by Manufacturers (2017-2022)
3.1.2 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-Malarial Drug Sales in 2021
3.2 Global Top Manufacturers Anti-Malarial Drug by Revenue
3.2.1 Global Anti-Malarial Drug Revenue by Manufacturers (2017-2022)
3.2.2 Top Anti-Malarial Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Anti-Malarial Drug Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2021)
3.4 Global Anti-Malarial Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-Malarial Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-Malarial Drug Market
3.7 Key Manufacturers Anti-Malarial Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Anti-Malarial Drug Market Size by Type
4.1 Global Anti-Malarial Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Anti-Malarial Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Anti-Malarial Drug Revenue Market Share by Type (2017-2022)
4.1.3 Anti-Malarial Drug Price by Type (2017-2022)
4.2 Global Anti-Malarial Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Anti-Malarial Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Anti-Malarial Drug Revenue Forecast by Type (2023-2028)
4.2.3 Anti-Malarial Drug Price Forecast by Type (2023-2028)
5 Global Anti-Malarial Drug Market Size by Application
5.1 Global Anti-Malarial Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Anti-Malarial Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Anti-Malarial Drug Revenue Market Share by Application (2017-2022)
5.1.3 Anti-Malarial Drug Price by Application (2017-2022)
5.2 Global Anti-Malarial Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Anti-Malarial Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Anti-Malarial Drug Revenue Forecast by Application (2023-2028)
5.2.3 Anti-Malarial Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Malarial Drug Sales Breakdown by Company
6.1.1 North America Anti-Malarial Drug Sales by Company (2017-2022)
6.1.2 North America Anti-Malarial Drug Revenue by Company (2017-2022)
6.2 North America Anti-Malarial Drug Market Size by Type
6.2.1 North America Anti-Malarial Drug Sales by Type (2017-2028)
6.2.2 North America Anti-Malarial Drug Revenue by Type (2017-2028)
6.3 North America Anti-Malarial Drug Market Size by Application
6.3.1 North America Anti-Malarial Drug Sales by Application (2017-2028)
6.3.2 North America Anti-Malarial Drug Revenue by Application (2017-2028)
6.4 North America Anti-Malarial Drug Market Size by Country
6.4.1 North America Anti-Malarial Drug Sales by Country (2017-2028)
6.4.2 North America Anti-Malarial Drug Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Anti-Malarial Drug Sales Breakdown by Company
7.1.1 Europe Anti-Malarial Drug Sales by Company (2017-2022)
7.1.2 Europe Anti-Malarial Drug Revenue by Company (2017-2022)
7.2 Europe Anti-Malarial Drug Market Size by Type
7.2.1 Europe Anti-Malarial Drug Sales by Type (2017-2028)
7.2.2 Europe Anti-Malarial Drug Revenue by Type (2017-2028)
7.3 Europe Anti-Malarial Drug Market Size by Application
7.3.1 Europe Anti-Malarial Drug Sales by Application (2017-2028)
7.3.2 Europe Anti-Malarial Drug Revenue by Application (2017-2028)
7.4 Europe Anti-Malarial Drug Market Size by Country
7.4.1 Europe Anti-Malarial Drug Sales by Country (2017-2028)
7.4.2 Europe Anti-Malarial Drug Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Malarial Drug Sales Breakdown by Company
8.1.1 Asia Pacific Anti-Malarial Drug Sales by Company (2017-2022)
8.1.2 Asia Pacific Anti-Malarial Drug Revenue by Company (2017-2022)
8.2 Asia Pacific Anti-Malarial Drug Market Size by Type
8.2.1 Asia Pacific Anti-Malarial Drug Sales by Type (2017-2028)
8.2.2 Asia Pacific Anti-Malarial Drug Revenue by Type (2017-2028)
8.3 Asia Pacific Anti-Malarial Drug Market Size by Application
8.3.1 Asia Pacific Anti-Malarial Drug Sales by Application (2017-2028)
8.3.2 Asia Pacific Anti-Malarial Drug Revenue by Application (2017-2028)
8.4 Asia Pacific Anti-Malarial Drug Market Size by Region
8.4.1 Asia Pacific Anti-Malarial Drug Sales by Region
8.4.2 Asia Pacific Anti-Malarial Drug Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Anti-Malarial Drug Sales Breakdown by Company
9.1.1 Latin America Anti-Malarial Drug Sales by Company (2017-2022)
9.1.2 Latin America Anti-Malarial Drug Revenue by Company (2017-2022)
9.2 Latin America Anti-Malarial Drug Market Size by Type
9.2.1 Latin America Anti-Malarial Drug Sales by Type (2017-2028)
9.2.2 Latin America Anti-Malarial Drug Revenue by Type (2017-2028)
9.3 Latin America Anti-Malarial Drug Market Size by Application
9.3.1 Latin America Anti-Malarial Drug Sales by Application (2017-2028)
9.3.2 Latin America Anti-Malarial Drug Revenue by Application (2017-2028)
9.4 Latin America Anti-Malarial Drug Market Size by Country
9.4.1 Latin America Anti-Malarial Drug Sales by Country (2017-2028)
9.4.2 Latin America Anti-Malarial Drug Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Malarial Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Anti-Malarial Drug Sales by Company (2017-2022)
10.1.2 Middle East and Africa Anti-Malarial Drug Revenue by Company (2017-2022)
10.2 Middle East and Africa Anti-Malarial Drug Market Size by Type
10.2.1 Middle East and Africa Anti-Malarial Drug Sales by Type (2017-2028)
10.2.2 Middle East and Africa Anti-Malarial Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa Anti-Malarial Drug Market Size by Application
10.3.1 Middle East and Africa Anti-Malarial Drug Sales by Application (2017-2028)
10.3.2 Middle East and Africa Anti-Malarial Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa Anti-Malarial Drug Market Size by Country
10.4.1 Middle East and Africa Anti-Malarial Drug Sales by Country (2017-2028)
10.4.2 Middle East and Africa Anti-Malarial Drug Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Anti-Malarial Drug Products and Services
11.1.5 GlaxoSmithKline Anti-Malarial Drug SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Ranbaxy
11.2.1 Ranbaxy Corporation Information
11.2.2 Ranbaxy Overview
11.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Ranbaxy Anti-Malarial Drug Products and Services
11.2.5 Ranbaxy Anti-Malarial Drug SWOT Analysis
11.2.6 Ranbaxy Recent Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Corporation Information
11.3.2 Zydus Cadila Overview
11.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Zydus Cadila Anti-Malarial Drug Products and Services
11.3.5 Zydus Cadila Anti-Malarial Drug SWOT Analysis
11.3.6 Zydus Cadila Recent Developments
11.4 Alvizia
11.4.1 Alvizia Corporation Information
11.4.2 Alvizia Overview
11.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Alvizia Anti-Malarial Drug Products and Services
11.4.5 Alvizia Anti-Malarial Drug SWOT Analysis
11.4.6 Alvizia Recent Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Overview
11.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Bayer Anti-Malarial Drug Products and Services
11.5.5 Bayer Anti-Malarial Drug SWOT Analysis
11.5.6 Bayer Recent Developments
11.6 Ipca
11.6.1 Ipca Corporation Information
11.6.2 Ipca Overview
11.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Ipca Anti-Malarial Drug Products and Services
11.6.5 Ipca Anti-Malarial Drug SWOT Analysis
11.6.6 Ipca Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Merck Anti-Malarial Drug Products and Services
11.7.5 Merck Anti-Malarial Drug SWOT Analysis
11.7.6 Merck Recent Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Corporation Information
11.8.2 F. Hoffmann-La Roche Overview
11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Products and Services
11.8.5 F. Hoffmann-La Roche Anti-Malarial Drug SWOT Analysis
11.8.6 F. Hoffmann-La Roche Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Novartis Anti-Malarial Drug Products and Services
11.9.5 Novartis Anti-Malarial Drug SWOT Analysis
11.9.6 Novartis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Pfizer Anti-Malarial Drug Products and Services
11.10.5 Pfizer Anti-Malarial Drug SWOT Analysis
11.10.6 Pfizer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-Malarial Drug Value Chain Analysis
12.2 Anti-Malarial Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Malarial Drug Production Mode & Process
12.4 Anti-Malarial Drug Sales and Marketing
12.4.1 Anti-Malarial Drug Sales Channels
12.4.2 Anti-Malarial Drug Distributors
12.5 Anti-Malarial Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Anti-Malarial Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Plasmodium Falciparum
Table 3. Major Manufacturers of Plasmodium Vivax
Table 4. Major Manufacturers of Plasmodium Malariae
Table 5. Major Manufacturers of Plasmodium Ovale
Table 6. Global Anti-Malarial Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anti-Malarial Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Anti-Malarial Drug Sales by Region (2017-2022) & (K Units)
Table 9. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)
Table 10. Global Anti-Malarial Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anti-Malarial Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Anti-Malarial Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Anti-Malarial Drug Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Anti-Malarial Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Anti-Malarial Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Anti-Malarial Drug Market Trends
Table 18. Anti-Malarial Drug Market Drivers
Table 19. Anti-Malarial Drug Market Challenges
Table 20. Anti-Malarial Drug Market Restraints
Table 21. Global Anti-Malarial Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Anti-Malarial Drug Sales Share by Manufacturers (2017-2022)
Table 23. Global Anti-Malarial Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Anti-Malarial Drug Manufacturers by Revenue (US$ Million) in 2021
Table 25. Anti-Malarial Drug Revenue Share by Manufacturers (2017-2022)
Table 26. Global Anti-Malarial Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2021)
Table 28. Key Manufacturers Anti-Malarial Drug Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Anti-Malarial Drug Plants/Factories Distribution
Table 30. Key Manufacturers Anti-Malarial Drug Area Served
Table 31. Date of Key Manufacturers Enter into Anti-Malarial Drug Market
Table 32. Key Manufacturers Anti-Malarial Drug Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Anti-Malarial Drug Sales (K Units) by Type (2017-2022)
Table 35. Global Anti-Malarial Drug Sales Share by Type (2017-2022)
Table 36. Global Anti-Malarial Drug Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Anti-Malarial Drug Price (K Units) by Type (2017-2022)
Table 38. Global Anti-Malarial Drug Sales (K Units) by Type (2023-2028)
Table 39. Global Anti-Malarial Drug Sales Share by Type (2023-2028)
Table 40. Global Anti-Malarial Drug Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Anti-Malarial Drug Revenue Share by Type (2023-2028)
Table 42. Global Anti-Malarial Drug Price (K Units) by Type (2023-2028)
Table 43. Global Anti-Malarial Drug Sales (K Units) by Application (2017-2022)
Table 44. Global Anti-Malarial Drug Sales Share by Application (2017-2022)
Table 45. Global Anti-Malarial Drug Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Anti-Malarial Drug Price (K Units) by Application (2017-2022)
Table 47. Global Anti-Malarial Drug Sales (K Units) by Application (2023-2028)
Table 48. Global Anti-Malarial Drug Sales Share by Application (2023-2028)
Table 49. Global Anti-Malarial Drug Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Anti-Malarial Drug Revenue Share by Application (2023-2028)
Table 51. Global Anti-Malarial Drug Price (K Units) by Application (2023-2028)
Table 52. North America Anti-Malarial Drug Sales by Company (2017-2022) & (K Units)
Table 53. North America Anti-Malarial Drug Sales Market Share by Company (2017-2022)
Table 54. North America Anti-Malarial Drug Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Anti-Malarial Drug Revenue Market Share by Company (2017-2022)
Table 56. North America Anti-Malarial Drug Sales by Type (2017-2022) & (K Units)
Table 57. North America Anti-Malarial Drug Sales by Type (2023-2028) & (K Units)
Table 58. North America Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Anti-Malarial Drug Sales by Application (2017-2022) & (K Units)
Table 61. North America Anti-Malarial Drug Sales by Application (2023-2028) & (K Units)
Table 62. North America Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Anti-Malarial Drug Sales by Country (2017-2022) & (K Units)
Table 65. North America Anti-Malarial Drug Sales by Country (2023-2028) & (K Units)
Table 66. North America Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Anti-Malarial Drug Sales by Company (2017-2022) & (K Units)
Table 69. Europe Anti-Malarial Drug Sales Market Share by Company (2017-2022)
Table 70. Europe Anti-Malarial Drug Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Anti-Malarial Drug Revenue Market Share by Company (2017-2022)
Table 72. Europe Anti-Malarial Drug Sales by Type (2017-2022) & (K Units)
Table 73. Europe Anti-Malarial Drug Sales by Type (2023-2028) & (K Units)
Table 74. Europe Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Anti-Malarial Drug Sales by Application (2017-2022) & (K Units)
Table 77. Europe Anti-Malarial Drug Sales by Application (2023-2028) & (K Units)
Table 78. Europe Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Anti-Malarial Drug Sales by Country (2017-2022) & (K Units)
Table 81. Europe Anti-Malarial Drug Sales by Country (2023-2028) & (K Units)
Table 82. Europe Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Anti-Malarial Drug Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Anti-Malarial Drug Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Anti-Malarial Drug Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Anti-Malarial Drug Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Anti-Malarial Drug Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Anti-Malarial Drug Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Anti-Malarial Drug Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Anti-Malarial Drug Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Anti-Malarial Drug Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Anti-Malarial Drug Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Anti-Malarial Drug Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Anti-Malarial Drug Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Anti-Malarial Drug Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Anti-Malarial Drug Sales Market Share by Company (2017-2022)
Table 102. Latin America Anti-Malarial Drug Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Anti-Malarial Drug Revenue Market Share by Company (2017-2022)
Table 104. Latin America Anti-Malarial Drug Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Anti-Malarial Drug Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Anti-Malarial Drug Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Anti-Malarial Drug Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Anti-Malarial Drug Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Anti-Malarial Drug Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Anti-Malarial Drug Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Anti-Malarial Drug Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Anti-Malarial Drug Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Anti-Malarial Drug Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Anti-Malarial Drug Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Anti-Malarial Drug Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Anti-Malarial Drug Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Anti-Malarial Drug Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Anti-Malarial Drug Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Anti-Malarial Drug Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Anti-Malarial Drug Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Anti-Malarial Drug Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Anti-Malarial Drug Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Anti-Malarial Drug Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Anti-Malarial Drug Revenue by Country (2023-2028) & (US$ Million)
Table 132. GlaxoSmithKline Corporation Information
Table 133. GlaxoSmithKline Description and Overview
Table 134. GlaxoSmithKline Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. GlaxoSmithKline Anti-Malarial Drug Product and Services
Table 136. GlaxoSmithKline Anti-Malarial Drug SWOT Analysis
Table 137. GlaxoSmithKline Recent Developments
Table 138. Ranbaxy Corporation Information
Table 139. Ranbaxy Description and Overview
Table 140. Ranbaxy Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Ranbaxy Anti-Malarial Drug Product and Services
Table 142. Ranbaxy Anti-Malarial Drug SWOT Analysis
Table 143. Ranbaxy Recent Developments
Table 144. Zydus Cadila Corporation Information
Table 145. Zydus Cadila Description and Overview
Table 146. Zydus Cadila Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Zydus Cadila Anti-Malarial Drug Product and Services
Table 148. Zydus Cadila Anti-Malarial Drug SWOT Analysis
Table 149. Zydus Cadila Recent Developments
Table 150. Alvizia Corporation Information
Table 151. Alvizia Description and Overview
Table 152. Alvizia Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. Alvizia Anti-Malarial Drug Product and Services
Table 154. Alvizia Anti-Malarial Drug SWOT Analysis
Table 155. Alvizia Recent Developments
Table 156. Bayer Corporation Information
Table 157. Bayer Description and Overview
Table 158. Bayer Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 159. Bayer Anti-Malarial Drug Product and Services
Table 160. Bayer Anti-Malarial Drug SWOT Analysis
Table 161. Bayer Recent Developments
Table 162. Ipca Corporation Information
Table 163. Ipca Description and Overview
Table 164. Ipca Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 165. Ipca Anti-Malarial Drug Product and Services
Table 166. Ipca Anti-Malarial Drug SWOT Analysis
Table 167. Ipca Recent Developments
Table 168. Merck Corporation Information
Table 169. Merck Description and Overview
Table 170. Merck Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 171. Merck Anti-Malarial Drug Product and Services
Table 172. Merck Anti-Malarial Drug SWOT Analysis
Table 173. Merck Recent Developments
Table 174. F. Hoffmann-La Roche Corporation Information
Table 175. F. Hoffmann-La Roche Description and Overview
Table 176. F. Hoffmann-La Roche Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 177. F. Hoffmann-La Roche Anti-Malarial Drug Product and Services
Table 178. F. Hoffmann-La Roche Anti-Malarial Drug SWOT Analysis
Table 179. F. Hoffmann-La Roche Recent Developments
Table 180. Novartis Corporation Information
Table 181. Novartis Description and Overview
Table 182. Novartis Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 183. Novartis Anti-Malarial Drug Product and Services
Table 184. Novartis Anti-Malarial Drug SWOT Analysis
Table 185. Novartis Recent Developments
Table 186. Pfizer Corporation Information
Table 187. Pfizer Description and Overview
Table 188. Pfizer Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 189. Pfizer Anti-Malarial Drug Product and Services
Table 190. Pfizer Anti-Malarial Drug SWOT Analysis
Table 191. Pfizer Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Anti-Malarial Drug Distributors List
Table 195. Anti-Malarial Drug Customers List
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Malarial Drug Product Picture
Figure 2. Global Anti-Malarial Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Plasmodium Falciparum Product Picture
Figure 4. Plasmodium Vivax Product Picture
Figure 5. Plasmodium Malariae Product Picture
Figure 6. Plasmodium Ovale Product Picture
Figure 7. Global Anti-Malarial Drug Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy Use Case
Figure 9. Retail Pharmacy Use Case
Figure 10. E-Commerce Use Case
Figure 11. Others Use Case
Figure 12. Anti-Malarial Drug Report Years Considered
Figure 13. Global Anti-Malarial Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-Malarial Drug Market Size 2017-2028 (US$ Million)
Figure 15. Global Anti-Malarial Drug Sales (2017-2022) & (K Units)
Figure 16. Global Anti-Malarial Drug Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Anti-Malarial Drug Sales Market Share by Region (2017-2022)
Figure 18. Global Anti-Malarial Drug Sales Market Share by Region in 2021
Figure 19. Global Anti-Malarial Drug Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Anti-Malarial Drug Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Malarial Drug Sales in 2021
Figure 22. Anti-Malarial Drug Revenue Share by Manufacturers in 2021
Figure 23. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Anti-Malarial Drug Revenue Share by Type (2017-2022)
Figure 25. Global Anti-Malarial Drug Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Anti-Malarial Drug Revenue Share by Application (2017-2022)
Figure 27. Global Anti-Malarial Drug Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 29. North America Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
Figure 30. North America Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 31. North America Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
Figure 32. North America Anti-Malarial Drug Sales Share by Country (2017-2028)
Figure 33. North America Anti-Malarial Drug Revenue Share by Country (2017-2028)
Figure 34. U.S. Anti-Malarial Drug Revenue (2017-2028) & (US$ Mill
Write comment about above report:
Related Reports
|
Global Anti-Malarial Drug Market Growth 2022-2028
As the global economy mends, the 2021 growth of Anti-Malarial Drug will have significant change from previous year. According to our (LP Information) latest study, the global Anti-Malarial Drug market size is USD million in 2022 from USD 667.7 millio... |
|
Global Anti-Malarial Drug Market Growth 2021-2026
According to this latest study, the 2020 growth of Anti-Malarial Drug will have significant change from previous year. By the most conservative estimates of global Anti-Malarial Drug market size (most likely outcome) will be a year-over-year revenue ... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays